BULLFROG AI HOLDINGS, INC. Retained Earnings
BULLFROG AI HOLDINGS, INC. (BFRG) had Retained Earnings of -$26.26 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$26.26M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$24.88M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$23.29M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$21.81M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$26.26M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$24.88M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$23.29M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$21.81M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$20.26M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$18.81M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$16.79M 10-K · filed 2026-03-19 |
| 2024-09-30 | -$15.05M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$13.29M 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$11.68M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$9.75M 10-K · filed 2025-03-14 |
| 2023-09-30 | -$8.46M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$7.21M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$5.72M 10-Q · filed 2023-05-24 |
| 2022-12-31 | -$4.40M 10-K · filed 2024-03-29 |
| 2021-12-31 | -$1.60M 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |